Guardian Pharmacy Services Inc (NYSE:GRDN)
$ 40.96 -0.10 (-0.24%) Market Cap: 2.59 Bil Enterprise Value: 2.58 Bil PE Ratio: 49.35 PB Ratio: 11.74 GF Score: 42/100

Q4 2025 Guardian Pharmacy Services Inc Earnings Call Transcript

Mar 11, 2026 / 08:30PM GMT
Release Date Price: $33.51 (-0.42%)

Key Points

Positve
  • Guardian Pharmacy Services Inc (GRDN) reported a strong financial performance for 2025, with organic revenue growth of 13% and overall revenue growth of 18% due to acquisitions.
  • Adjusted EBITDA grew by 27% year-over-year, with margins expanding by 50 basis points to 7.9%, demonstrating effective cost management and operational efficiency.
  • The company successfully integrated acquisitions and expanded its operational footprint, particularly in the Pacific Northwest, contributing to its growth.
  • Guardian's vaccine clinics administered over 120,000 vaccines, resulting in a 9% increase in script volumes and improved profitability.
  • The company increased its cash balance by approximately $60 million, highlighting its strong cash-generating capabilities and financial flexibility.
Negative
  • The introduction of the IRA has created operational complexities and pricing challenges, impacting the long-term care pharmacy ecosystem.
  • Guardian Pharmacy Services Inc (GRDN) faces pressure from industry changes, including consolidation at the facility level and increasing operational complexity.
  • The company is navigating the unintended consequences of the American Rescue Plan, which has created headwinds in the branded inhaler category.
  • Despite strong performance, the integration of new acquisitions has dampened overall margins by approximately 90 basis points.
  • The company anticipates a $65 million revenue headwind in 2027 due to additional branded drug negotiations under the IRA.
Operator

Good afternoon, ladies and gentlemen, and welcome to the Guardian Pharmacy Services fourth-quarter earnings release conference call. (Operator Instructions) This call is being recorded on Wednesday, March 11, 2026.

And I would now like to turn the conference over to Ashley Stockton. Please go ahead.

Ashley Stockton
Guardian Pharmacy Services Inc - Head of Investor Relations

Good afternoon. Thank you for participating in today's conference call. My name is Ashley Stockton, Vice President, Investor Relations for Guardian Pharmacy Services. I'm joined on today's call by Fred Burke, President and Chief Executive Officer; and David Morris, Chief Financial Officer. After the close today, Guardian posted its financial results for the quarter ended December 31, 2025.

A copy of the press release is available on the company's Investor Relations website. Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot